Skip to Content

Logo 5623 150 mg (Nizatidine 150 mg)

Pill with imprint Logo 5623 150 mg is White & Yellow, Capsule-shape and has been identified as Nizatidine 150 mg. It is supplied by Teva Pharmaceuticals USA.

Nizatidine is used in the treatment of erosive esophagitis; gerd; duodenal ulcer prophylaxis; duodenal ulcer; indigestion (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo 5623 150 mg

Nizatidine

Imprint:
Logo 5623 150 mg
Strength:
150 mg
Color:
White & Yellow
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00172-5623

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide